This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Dow Dogs That Are Barking for Gains


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Big pharma giant Merck (MRK - Get Report) takes the No. 3 spot on the Dow with a yield of 4.35%. Pharma stocks in general tend to have higher payouts right now, the result of Mr. Market's discounting for the massive black clouds of patent dropoffs overhead. With most major pharmaceutical stocks losing key drugs in the next couple of years, investors are understandably concerned. But Merck is has some defenses against the loss of blockbuster names like Singulair.

One of the biggest defensive moves was the acquisition of Schering-Plough in 2009, a purchase that dramatically expanded its late-stage pipeline and grew its consumer products exposure. While there are still some major unknowns in Merck's pipeline, it certainly beats not having a backup plan. This company generates significant cash right now -- as a result, it's got the wherewithal to handle some revenue bumps in the near-term.

At this point, patent risks are already priced into shares.

Merck shows up on a recent list of 10 Dividend Stocks Held by Highly Rated Fund Managers.

4 of 11

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
DD $54.65 -1.00%
CVX $86.71 -0.32%
MRK $50.44 1.30%
T $33.08 0.73%
AAPL $109.54 -1.60%


Chart of I:DJI
DOW 16,778.37 -11.82 -0.07%
S&P 500 1,976.44 -3.48 -0.18%
NASDAQ 4,728.8240 -19.5370 -0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs